الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 112 |  |  |
| | | from | 112 | | |
Abstract
Anemia is one of the most prevalent complications during pregnancy. It is commonly considered a risk factor for poor pregnancy outcomes and can result in complications that threaten the life of both mother and fetus, such as preterm birth, low birth weight (Banhidy et al., 2011).
There is clear evidence to support prompt treatment in all patients with iron deficiency anemia because it is known that treatment improves quality of life and physical condition as well as alleviates fatigue and cognitive deficits (Falkingham et al., 2010).
This study aimed to evaluate the value of addition of vitamin B6 to iron in treatment of iron deficiency anemia in pregnant women during second trimester.
The study was done through giving anemia pregnant women iron therapy and vitamin B6 which represent group A and iron therapy alone it represents group B.
For each pregnant woman, age, parity and gestational history were taken before treatment. All pregnant women took their allocated treatment regularly for three weeks after diagnosis of iron deficiency anemia with CBC and followed up after three weeks.
Also epigastric pain, diarrhea, constipation, nausea, vomiting or gastric distress reported to assess tolerability of the drugs.
Results of the study revealed that there was statistically significant difference between the two groups of therapy according to the hemoglobin level.
And there was a significant difference in the rate of change of hemoglobin and body mass index.